Development of a Simple, Precise, and Validated HPLC Method for the Anticancer Drug, Regorafenib: Application to Pharmacokinetics in Rats and Stability Study
- Authors
- Kim, Jung Suk; Cho, Jung Hyun; Choi, Han-Gon
- Issue Date
- Sep-2021
- Publisher
- 대한화학회
- Keywords
- Regorafenib; High-performance liquid chromatography-ultraviolet; Validation; Stability; Pharmacokinetics
- Citation
- Bulletin of the Korean Chemical Society, v.42, no.9, pp 1239 - 1244
- Pages
- 6
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- Bulletin of the Korean Chemical Society
- Volume
- 42
- Number
- 9
- Start Page
- 1239
- End Page
- 1244
- URI
- https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/116251
- DOI
- 10.1002/bkcs.12355
- ISSN
- 0253-2964
1229-5949
- Abstract
- The goal of this study was to establish a simple, precise, and validated high-performance liquid chromatography-ultraviolet (HPLC-UV) method to quantify the amount of regorafenib in rat plasma using revaprazan as an internal standard. The mobile phase composition was 0.1% aqueous trifluoroacetic acid solution and 0.1% trifluoroacetic acid in acetonitrile (50/50, v/v). The flow rate was 0.5 mL/min, and the eluent was monitored at 265 nm. The results showed that this novel chromatographic method achieved the criteria of the FDA validation guidelines and presented excellent linearity over 0.0488-50 mu g/mL (r(2) = 0.9999) concentration. Additionally, this method was validated for evaluating regorafenib stability in three different storage conditions and was effectively utilized to analyze the drug concentration in rat plasma after oral administration by calculating its pharmacokinetic parameters. Therefore, this HPLC method is appropriate for evaluating the pharmacokinetics of regorafenib in rats.
- Files in This Item
-
Go to Link
- Appears in
Collections - COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/116251)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.